The presented development of income and expenses resulted in a very sharp increase in the division’s operating result (EBIT) in 2013, of 63.1% to € 893 million (2012: € 548 million). After eliminating depreciation and amortization, and adjusted for one-time effects, EBITDA pre one-time items rose by 7.1% to € 1,955 million (2012: € 1,825 million), corresponding to a margin of 32.8% of sales (2012: 30.4%).
| XLS |
|
Merck Serono | Reconciliation EBIT to EBITDA pre one-time items |
|||
|
|
|
|
|
|
|
|
|
|
|
€ million |
2013 |
2012 |
Change in % |
|
Operating result (EBIT) |
893.0 |
547.7 |
63.1 |
|
Depreciation/Amortization/Reversals of impairments |
993.5 |
932.3 |
6.6 |
|
EBITDA |
1,886.5 |
1,480.0 |
27.5 |
|
One-time items |
68.5 |
344.7 |
–80.1 |
|
EBITDA pre one-time items |
1,955.0 |
1,824.7 |
7.1 |
The development of EBITDA pre one-time items in the individual quarters in comparison with 2012 is presented in the following table:
Merck Serono | EBITDA pre one-time tems and change by quarter 1
back
